HEALTHMEDPAGE TODAY
New Strategies and Platforms for Gastroesophageal Cancer
Improved understanding of the tumor microenvironment and genomics has led to new therapies for gastroesophageal and esophageal cancer, potentially improving patient outcomes. Some of these therapies have already transitioned from research to application.
Mentioned
Related Signal
Adjacent reporting
- Pancreatic cancer: Dr. Pudlarz praises 'new generation targeted therapy' that inhibits gene mutation
- Giant cancer study reveals effectiveness of ‘off label’ treatments
- Evolution of Perioperative Immunotherapy in Resectable Esophageal Cancer
- STAT+: Astellas treatment offers new hope to a devastated rare disease community
- STAT+: Pharmalittle: We’re reading about pancreatic and lung cancer drugs, China biotech growth, and more
- New drugs take aim at one of cancer’s deadliest mutations